This study was designed to compare between the stress protein HSP70 immunoexpression in the urinary bladder cancer (UBC) and bladder benign tumor Accordingly,HSP70 can be investigated as an omen biomarker in bladder cancer .
. HSP70s is the most indispensable HSPs for protein folding and is highly associated with tumor advancement , which may also supply therapeutic strategy of cancer [4] .
HSP70 is marginally expressed in normal cells , but is over expressed in malignancy cells, and in general hopeless prognosis, increased tumor grade and drug resistance of various cancers are related with elevated levels of this protein [5] , [6] .
So the goal of this Study to detect the significant biological association between bladder carcinoma (BC) and protein tissue expression of HSP70 as a diagnostic biomarker marker in Iraqi patients with BC by using Immunohistochemical technique (IHC) with HSP70 -monoclonal antibody .
Material & Methods
Fifty biopsies from patients with urinary bladder carcinoma (UBC) were included in this study, the patient samples were collected from AL-Yarmook [7] . The bladder epithelia showed intense staining of HSP70 (Figure 1) , and also it was found in all layers of bladder transitional epithelium . Our results corresponds with the data postulated that HSPs may suppress program death and thus promote tumorigenesis [8] . In terms of scores, UBC patients with the score ++ represented the highest frequency (48.6%), and a similar observation was made in BT patients but the frequency was higher (60%). However, (Table 2) showed the frequency 
Conclusion
The high significant differences in the IHC expression score of HSP70 in BC compared with BT and elevated expression in patients with high grades of UBC have led to HSP70 being investigated as a prognostic biomarker in bladder cancer . 
